Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00093275 | HP184 in Chronic Spinal Cord Injury Subjects | PHASE2 | COMPLETED | 262 | — | — | Oct 1, 2004 | Dec 1, 2005 | Aug 21, 2008 | 5 | United States, Australia +3 |
| Name | Type | Description |
|---|---|---|
| HP184 | DRUG | - |
Inclusion Criteria: * Male and female subjects with incomplete (traumatic), chronic (defined as 18 months or more post spinal cord injury) SCI aged 18 to 65 years * CSCI must be categorized in classes C or D in the ASIA impairment scale. (C = Incomplete impairment with motor function preserved belo...